title: Pemphigus foliaceus treated with etanercept.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Gubinelli
authors.forename: Fabio
authors.initials: F
authors.lastname: Bergamo
authors.forename: Biagio
authors.initials: B
authors.lastname: Didona
authors.forename: Giorgio
authors.initials: G
authors.lastname: Annessi
authors.forename: Francesco
authors.initials: F
authors.lastname: Atzori
authors.forename: Desanka
authors.initials: D
authors.lastname: Raskovic
mesh_terms: D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008875:Middle Aged; D010392:Pemphigus / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012074:Remission Induction; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000037:antagonists & inhibitors*
chemical_list: D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept